These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35051331)
1. Local Destruction of Tumors for Systemic Immunoresponse: Engineering Antigen-Capturing Nanoparticles as Stimulus-Responsive Immunoadjuvants. Lu J; Guo Z; Zheng R; Xie W; Gao X; Gao J; Zhang Y; Xu W; Ye J; Guo X; Tang J; Yu J; Wang L; Xu B; Zhang G; Zhao L ACS Appl Mater Interfaces; 2022 Feb; 14(4):4995-5008. PubMed ID: 35051331 [TBL] [Abstract][Full Text] [Related]
2. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy. Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006 [TBL] [Abstract][Full Text] [Related]
3. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect. Chen B; Huang R; Zeng W; Wang W; Min Y Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501 [TBL] [Abstract][Full Text] [Related]
4. Immunoadjuvants for cancer immunotherapy: A review of recent developments. Banstola A; Jeong JH; Yook S Acta Biomater; 2020 Sep; 114():16-30. PubMed ID: 32777293 [TBL] [Abstract][Full Text] [Related]
5. Combination of PEG-decorated black phosphorus nanosheets and immunoadjuvant for photoimmunotherapy of melanoma. Wan S; Zhang B; Li S; He B; Pu Y J Mater Chem B; 2020 Apr; 8(14):2805-2813. PubMed ID: 32163088 [TBL] [Abstract][Full Text] [Related]
7. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy. Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312 [TBL] [Abstract][Full Text] [Related]
8. Liquid Metal Nanoplatform Based Autologous Cancer Vaccines. Wang D; Yu Z; Qi Y; Hu K; Zhou T; Liu J; Rao W ACS Nano; 2023 Jul; 17(14):13278-13295. PubMed ID: 37253081 [TBL] [Abstract][Full Text] [Related]
9. Photothermal-Activatable Fe Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757 [TBL] [Abstract][Full Text] [Related]
10. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer. Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587 [TBL] [Abstract][Full Text] [Related]
11. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view. Huang X; Lu Y; Guo M; Du S; Han N Theranostics; 2021; 11(15):7546-7569. PubMed ID: 34158866 [TBL] [Abstract][Full Text] [Related]
12. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075 [TBL] [Abstract][Full Text] [Related]
13. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor. Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008 [TBL] [Abstract][Full Text] [Related]
14. A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy. Dong X; Liang J; Yang A; Qian Z; Kong D; Lv F ACS Appl Mater Interfaces; 2019 Feb; 11(5):4876-4888. PubMed ID: 30628437 [TBL] [Abstract][Full Text] [Related]
15. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy. Nguyen TL; Choi Y; Kim J Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454 [TBL] [Abstract][Full Text] [Related]
16. Zhu J; Li M; Zhang Y; Lv Z; Zhao Z; Guo Y; Chen Y; Ren X; Cheng X; Shi H ACS Nano; 2024 Jul; ():. PubMed ID: 39066710 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy. Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118 [TBL] [Abstract][Full Text] [Related]
18. Large-Pore Mesoporous-Silica-Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy. Ding B; Shao S; Yu C; Teng B; Wang M; Cheng Z; Wong KL; Ma P; Lin J Adv Mater; 2018 Dec; 30(52):e1802479. PubMed ID: 30387197 [TBL] [Abstract][Full Text] [Related]
19. Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study. Hao Y; Yasmin-Karim S; Moreau M; Sinha N; Sajo E; Ngwa W Phys Med Biol; 2016 Dec; 61(24):N697-N707. PubMed ID: 27910826 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy. Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]